A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: A case report

Journal of Korean Medical Science

Volumn 21, Issue 4, 2006, Pages 765-767

  Sung, Won Moon ^a   Jong, Ryeal Hahm ^a,b   Lee, Gyeong Won ^a,b   Mi, Yeon Kang ^a   Jung, Hwa Jung ^a   Tae, Sik Jung ^a   Kang, Wan Lee ^a   Kyoung, Ah Jung ^a   Yong, Jun Ahn ^a   Kim, Sunjoo ^a,b   Me, Ae Kim ^a,b   Deok, Ryong Kim ^a,b   Soon, Il Chung ^a,b   Myoung, Hee Park ^c  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

Author keywords

Diabetes Mellitus, Type 2; Graves Disease; HyperOsmolar Hyperglycemic Nonketotic Coma; Methymazole

Indexed keywords

EID: 33746886978     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.4.765     Document Type: Article

References (16)

1. Alvin CP. Diabetes mellitus. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, Isselbacher KJ, Eds. Harrison's Principles of Internal Medicine. 16th ed. McGraw-Hill 2004; 2152-80.
2. Bhattacharyya A, Wiles PG. Diabetic ketoacidosis precipitated by thyrotoxicosis. Postgrad Med J 1999; 75: 291-2.
3. Sola E, Morillas C, Garzon S, Gomez-Balaguer M, Hernandez-Mijares A. Association between diabetic ketoacidosis and thyrotoxicosis. Acta Diabetol 2002; 39: 235-7.
4. Kunishige M, Sekimoto E, Komatsu M, Bando Y, Uehara M, Izumi K. Thyrotoxicosis masked by diabetic ketoacidosis: a fatal complication. Diabetes Care 2001; 24: 171.
5. Gomez-Balaguer M, Saurina J, Gilsanz A, Alonso C. Non-ketoacidic hyperosmolar diabetic decompensation caused by hyperthyroidism. An infrequent fact. Med Clin (Barc) 1990; 94: 116-7.
6. Randin J, Tappy L, Scazziga B, Jequier E, Felber J. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and indirect calorimetry. Diabetes 1986; 35: 178-81.
7. Morrison W, Gibson J, Jung R, Rennie M. Skeletal muscle and whole body protein turnover in thyroid disease. Eur J Clin Invest 1998; 18: 62-8.
8. Beylot M, Martin C, Laville M, Riou JP, Cohen R, Mornex R. Lipolytic and ketogenic fluxes in human hyperthyroidism. J Clin Endocrinol Metab 1991; 73: 42-9.
9. Loeb JN. Metabolic changes in thyrotoxicosis. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The thyroid. Philadelphia: Lippincott-Raven 1996; 687-93.
10. Foss MC, Paccola GM, Saad MJ, Pimenta WP, Piccinato CE, Iazigi N. Peripheral glucose metabolism in human hyperthyroidism. J Clin Endocrinol Metab 1990; 70: 1167-72.
11. Utiger RD. The thyroid: physiology, thyrotoxicosis, hypothyroidism, and the painful thyroid. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and metabolism. New York: McGraw-Hill 1995; 435-519.
12. Hagenfeldt L, Wennlund A, Felig P, Wahren J. Turnover and splanchnic metabolism of free fatty acids in hyperthyroid patients. J Clin Invest 1981; 67: 1672-7.
13. Nijs HG, Radder JK, Foolich M, Krans HM. Increased insulin action and clearance in hyperthyroid newly diagnosed IDDM patient. Restoration to normal with antithyroid treatment. Diabetes Care 1989; 12: 319-24.
14. Wilson R, McKillop JH, Crocket GT, Pearson C, Jenkins C, Burns F, Burnett AK, Thopson JA. The effects of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease. Clin Endocrinol (Oxf) 1991; 34: 357-61.
15. Fradkin JE, Wolff J. Iodide-induced thyrotoxicosis. Medicine 1983; 62: 1-20.
16. Landsberg L. Catecholamines and hyperthyroidism. Clin Endocrinol Metab 1977; 6: 697-718.